Rafferty Asset Management
BDSI

Rafferty Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Rafferty Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,504
Closed -$38K – 1338
2021
Q2 		$38K Buy
+10,504
New +$37.1K ﹤0.01% 1252
2021
Q1 		– Sell
-11,146
Closed -$47K – 1184
2020
Q4 		$47K Buy
+11,146
New +$43K ﹤0.01% 1007

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Rafferty Asset Management's BDSI Position: Q3 2021 in Review

Rafferty Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2021, closing a stake of 10,504 shares — an estimated $38K sold.

Rafferty Asset Management first reported a position in BDSI in Q4 2020 and held it in 2 quarters. The position peaked at $47K in Q4 2020. 151 funds tracked by Wall St. Rank hold BDSI as of Q3 2021.

  • Rafferty Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2021 after selling out during the quarter.
  • Rafferty Asset Management sold 10,504 BioDelivery Sciences International, Inc. shares in Q3 2021, an estimated $38K.
  • Rafferty Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 2 quarters.
  • Rafferty Asset Management's BioDelivery Sciences International, Inc. position peaked at $47K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.